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Abstract
The Entamoeba histolytica transcription factor Upstream Regulatory Element 3-Binding Protein (URE3-BP) is a calcium-
responsive regulator of two E. histolytica virulence genes, hgl5 and fdx1. URE3-BP was previously identified by a yeast one-
hybrid screen of E. histolytica proteins capable of binding to the sequence TATTCTATT (Upstream Regulatory Element 3
(URE3)) in the promoter regions of hgl5 and fdx1. In this work, precise definition of the consensus URE3 element was
performed by electrophoretic mobility shift assays (EMSA) using base-substituted oligonucleotides, and the consensus motif
validated using episomal reporter constructs. Transcriptome profiling of a strain induced to produce a dominant-positive
URE3-BP was then used to identify additional genes regulated by URE3-BP. Fifty modulated transcripts were identified, and
of these the EMSA defined motif T[atg]T[tc][cg]T[at][tgc][tg] was found in over half of the promoters (54% p,0.0001).
Fifteen of the URE3-BP regulated genes were potential membrane proteins, suggesting that one function of URE3-BP is to
remodel the surface of E. histolytica in response to a calcium signal. Induction of URE3-BP leads to an increase in tranwell
migration, suggesting a possible role in the regulation of cellular motility.
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Introduction
The early branching eukaryote Entamoeba histolytica is a human
parasite that is the etiologic agent of amebic dysentery and liver
abscess. Only one of every five infections leads to disease [1], and
the parasite and host factors that control the outcome of infection
are not well understood. Alteration in transcription of certain
crucial genes may contribute to the expression of a virulence
phenotype. Distinct gene expression profiles which may be
associated with pathogenicity have been identified by comparing
the transcriptome of laboratory-cultured HM-1:IMSS E. histolytica
to trophozoites growing in vivo, as well as to that of less virulent
strains and recent clinical isolates [2,3,4,5,6].
Here we have attempted to study the molecular mechanisms
involved in the transcriptional regulation of virulence in E.
histolytica by investigating further the role of the upstream
regulatory element 3-binding protein (URE3-BP) transcription
factor.
URE3-BP is a calcium regulated transcription factor, that is
known to bind to the URE3 motif and thereby modulate
transcription of both the Gal/GalNAc-inhibitable lectin hgl5 and
ferredoxin 1 (fdx) genes. Mutation of the URE3 motif within the
hgl5 and fdx1 promoter led to a four-fold rise and a two-fold drop
in gene expression respectively, indicating that URE3 may
function as a repressor or activator depending on context [7,8].
Previously a yeast one hybrid screen was used to identify an E.
histolytica cDNA encoding a protein (URE3-BP) that recognized
the URE3 DNA motif [9]. The URE3-BP protein was present in
the E. histolytica nucleus and cytoplasm with an apparent molecular
mass of 22.6 KDa. Two EF-hand motifs were identified in the
amino acid sequence of URE3-BP. Binding of URE3-BP to the
URE3 motif was inhibited in vitro by addition of calcium. Mutation
of the second EF hand motif in URE3-BP resulted in the loss of
calcium inhibition of DNA binding, as monitored by an
electrophoretic mobility shift assay. Chromatin immunoprecipita-
tion experiments confirmed the calcium-dependent interaction of
URE3-BP with both the hgl5 and fdx1 promoter DNA [10].
Because the Gal/GalNAc inhibitable lectin is an important
virulence factor of E. histolytica it may be coordinately regulated at
the transcription level with other virulence genes. In this light, it
was intriguing that the mRNA of (URE3-BP) was down regulated
two-fold in vivo [2]. The discovery of direct downstream targets of
URE3-BP therefore may identify other genes important in E.
histolytica pathogenesis and help delineate molecular and cellular
mechanisms involved in the expression of virulence.
Position-specific variability in the sequence of transcription
factor binding sites renders recognition of valid targets by
computational methods alone extremely challenging [11,12] .
Most work has been performed in the yeast model organism or the
well-studied human transcriptome. The parameters affecting
www.plosntds.org 1 August 2008 | Volume 2 | Issue 8 | e282transcription regulation in early branching eukaryotes are only
beginning to be deciphered [4,13,14,15,16,17].
The sequencing of the E. histolytica genome identified homologues
of most of the RNA polymerase II subunits [18,19], however the
structure of E. histolytica core promoter varies from the conventional
norm by containing a third regulatory sequence GAAC in addition
to the TATA box and INR. This may have an unpredictable impact
on the machinery necessary for regulation of transcription [7,20]. A
bioinformatics approach was used by Hackney et al to correlate
potential E. histolytica DNA motifs with high and low gene expression
[21]. In our study we have focused on using not only computational
but also experimental approaches to discover the gene regulatory
network of the URE3-BP transcription factor.
To identify the consensus binding site sequence, a position
weight matrix (PWM) of transcription factor binding to the URE3
motif was developed. To test the validity of the matrix, selected
mutants within the URE3 motif of the hgl5 promoter were assessed
for promoter activity in an episomal reporter construct. Finally, to
identify additional genes regulated by URE3-BP, genome-wide
expression profiling of transcripts from strains over-expressing a
calcium insensitive URE3-BP mutant was performed.
Methods
Cultivation of E. histolytica and Nuclear Extract
Preparation
E. histolytica strain HM1:IMSS trophozoites were grown at 37uC
in TYI-S-33 medium containing penicillin (100 U/ml) and
streptomycin (100 mg/ml) (GIBCO/BRL)[22]. Amebae in loga-
rithmic phase growth (,6610
4 trophozoites/ml) were used for
nuclear extract preparation. Crude nuclear extracts were prepared
by the method previously described [8,23] with the following
modifications: the protease inhibitors 2 mM (2S,3S)-trans-epox-
ysuccinyl-L-leucylamido-3-methylbutane and 2 mM 4-(2-ami-
noethyl) benzenesulfonylfluoride, HCl were added to both cell
and nuclear lysis buffers, and dithiothreitol was omitted from the
nuclear lysis buffer.
Transient and stable transfection of E. histolytica
trophozoites
StabletransfectionofE.histolyticatrophozoiteswasachievedbyuse
of the previously described lipofection technique [24,25] . Briefly,
amebae were washed and suspended (2.2610
5 amebae per ml) in
Medium 199 (Invitrogen, CA) supplemented with 5.7 mM cysteine,
1 mM ascorbic acid, 25 mM HEPES pH 6.8 (M199s) 3 mgo fD N A
and 15 ml of Superfect (Qiagen) was added. Treated amebae were
left for 3 hours at 37uC, then growth media was added, and
incubation at 37uC was continued overnight. The expression of all
the recombinant proteins was confirmed by western blotting.
Nuclear and cytoplasmic extracts were prepared using standard
techniques [9]. Transfected amebae were selected with either G418
(6 mg/ml) or hygromycin (15 mg/ml). Transient transfection was
achieved using the electroporation protocol described by Purdy et al.
Briefly trophozoites were washed and suspended in 120 mM KCI,
0.15 mM CaCl2,1 0 m MK 2HPO4/KH2PO4, pH 7.5, 25 mM
HEPES,2 mMEGTA,5 mMMgC12,5 0mg/mlofplasmidand3.1
mg/ml of DEAE-dextran, and electroporated at 500 mF and 500 V/
cm (Gene Pulser, Bio-Rad) [7].
Electrophoretic Mobility Shift Analysis
URE3-BP, has been shown to bind specifically to the
TATTCTATT (URE3) DNA motif in Gilchrist et al 2001 [9].
In these conditions antibodies raised against URE3-BP blocked
the formation of the URE3 DNA-protein complex by native
nuclear extracts and competition with a 60 fold excess of the
nonspecific oligonucleotide (Olig-1) did not interfere with the
formation of the specific complex. EMSA assays were performed
with a Klenow-radiolabeled double stranded DNA oligonucleotide
that spans the URE3 motif within the hgl5 promoter
TGTTCCAAAAAGATATATTCTATTGAAAATAAAAGAAG
(hgl5-URE3). The protein-DNA interaction occurred in band shift
buffer (10 mM Tris-HCl [pH 7.9], 50 mM NaCl, 1 mM EDTA,
0.05% nonfat milk powder, 3% glycerol, 0.05 mg of bromophenol
blue) to which 0.2 mg of poly(dIdC), 10 fmol of DNA probe, and 2
mg of nuclear extract were added. The reaction mixture was
allowed to incubate at room temperature (20uC) for 1 h prior to
electrophoresis on a nondenaturing polyacrylamide gel for 2 to
3 h. The gel was then fixed and dried, and the signal from the
protein-DNA complex was quantitated after exposure of the gel to
a phosphorimage screen as described previously [8]. A ten fold or
six fold excess of either cold hgl5-URE3 (wt) or oligonucleotides
wherein a base pair alteration within the URE3 motif had been
made were added to the assay and the amount of competition was
quantitated using a PhosphorImager. A double stranded oligonu-
cleotide (Olig1) with the sequence AGAAAGCGTAATAGCTCA
was used as an irrelevant control. Experiments were performed in
triplicate, gels scanned (Molecular Dynamics, Model 425) and
relative density of the EMSA assessed by use of the ImageQuant
program (IQMac v1).
Stable and Inducible expression vectors
The stable construct (pHTP.luc) contained the luciferasestructural
gene under the control of the E. histolytica hgl5 gene [26]. The
promoter was mutated at the URE3 motif as described in results.
Inducible vectors were based on the tetracycline inducible gene
expression system of Ramakrishnan et al. [27]. An N-terminal myc
Author Summary
Most infections with Entamoeba histolytica are asymptom-
atic. However, in a minority of cases, they develop into
invasive and even life-threatening amebiasis. We suspect,
based on prior studies of invasive amebae, that changes in
amebic gene expression enable the transition from
asymptomatic to invasive infection. Our long-term goal is
to identify the genetic program required to cause amebic
colitis. Here, we studied a transcription factor named
URE3-BP that controls the expression of two virulence
genes, the Galactose and Galactose N- acetyl- galactos-
amine inhibitable lectin (Gal/GalNAc lectin) and ferredoxin.
We suspected that this factor might coordinate invasive-
ness by co-regulating additional virulence factors. The
consensus DNA motif that is recognized by URE3-BP was
identified by reporter gene assays and by electromobility
shift assays. We then inducibly expressed a constitutively
active form of the transcription factor, and measured the
changes in total amebic gene expression mediated by
overexpression of this dominant-positive version of URE3-
BP. This analysis allowed for a further definition of the
functional URE3 motif. Inducible expression of URE3-BP led
to changes in the transcript levels of several novel amebic
membrane proteins. In conclusion, this genome-wide
analysis of a transcription factor and its cis-acting
regulatory sequence in Entamoeba histolytica has identi-
fied new transcripts regulated by URE3-BP that may play a
role in trophozoite motility within a coordinated virulence-
specific gene regulatory network.
Targets of the Transcription Factor URE3-BP
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TGCGGATCCAAATGGAACAAAAATTAATTTCAGAAGAA-
GATTTA-ATGCAACCACCTGTAGCTAATTTCC, and a con-
trol generated using an oligonucleotide that incorporated two stop
codons directly after the myc tag (CTTGTATTTAACAATAGC-
TAACATC). Both amplicons were subcloned into the pCR2.1
TOPO expression vector (Invitrogen) and sequenced to confirm the
presence of the desired mutations. The DNAs were then subcloned
into the tetracycline-inducible gene expression system.
RNA isolation
One ml of Trizol (Invitrogen) was added to 2610
6 amebae
collected by centrifugation at 900 rpm for 5 min and an initial
RNA preparation performed according to the manufacturer’s
directions. RNA greater than 200 nucleotides in length was
separated from total RNA by the RNeasy protocol (Qiagen). RNA
was isolated from at least two independent cultures on the same
day for microarray analysis.
qRT-PCR
Reverse transcription real time PCR (qRT-PCR) was used to
independently measure mRNA abundance in independently trans-
formed amebae. The cDNA was subjected to 40 amplification cycles
with HotStarTaq (Qiagen). Primers were designed to amplify 100–
300 base pairs using genomic sequences from the E. histolytica
Genome Sequencing Project (http://www.tigr.org/tdb/e2k1/eha1/,
http://pathema.tigr.org/tigr-scripts/Entamoeba/PathemaHome
Page.cgi) and the Primer3 program (Table S1) [28]. The
fluorescent dye SYBR Green I (Molecular Probes) was used to
detect amplified cDNA. Continuous SYBR Green I monitoring
during amplification using the MJR Opticon II machine was
done according to the manufacturer’s recommendations. All real
time amplification reactions were performed in triplicate and the
resulting fluorescent values averaged. In all experiments utilizing
qRT-PCR the cycle threshold values (CT, the cycle number at
which fluorescence exceeds the threshold value) were linked to
the quantity of initial DNA after calibration of the effectiveness
of the amplifying primer pair [29]. The relatively invariant lgl1
transcript was used to compensate for the variation in the
amount of amebic mRNA isolated.
Hybridization of sample to the Affymetrix E_his-
1a520285 custom array
Quality control of RNA samples was performed by use of the
Agilent Bioanalyser Nano Assay. The standard protocol for
hybridization of eukaryotic mRNA to Affymetrix arrays was followed
(http://www.affymetrix.com/support/technical/manual/expression_
manual.affx). Two micrograms of total RNA was used for
cDNA and subsequent biotinylated cRNA synthesis. This
labeled RNA probe was hybridized to the Affymetrix custom
array designed using information generated from the E. histolytica
genome sequencing project release date 12/08/04 as previously
described [2,18]. The affymetrix probes were mapped to the
new Genome Assembly and recognized 6385 of the reannotated
open reading frames (78% of E. histolytica Open Reading Frames
(ORF) 8197 http://pathema.tigr.org/). The ORF probe sets
were preferentially selected from the 600 bases proximal to the
39 end of the E. histolytica sequences. The arrays were scanned
with an Affymetrix Gene Chip scanner 7G and report files were
generated to determine the percentage of present calls of each
array. The detection calls (present, marginal, absent) for each
probe set were obtained using the GCOS system (http://www.
affymetrix.com/products/software/specific/gcos.affx). Only genes
with at least one ‘‘present’’ call were used in assessment of the
data. Raw data from the arrays were normalized at probe level
by the gcRMA algorithm and then log2 transformed [30].
Genome analysis and datasets2 The dataset used in this analysis was
that of the reannotated E. histolytica genome of Caler et al.
(manuscript in preparation) publicly available at http://pathema.
tigr.org (Genebank accession number (AAFB00000000)). The
reannotated genome was searched for the URE3 motif with a
custom motif search script (Table 1).
Table 1. Presence of the URE3 matrix in the promoters of genes modulated by a dominant positive URE3-BP
Promoters which did not
contain a URE3 matrix
Promoters containing
a URE3 matrix 375-25
bases 59 of ATG start
codon
Total Number of
Promoters
analyzed %
Statistical
significance
Transcripts significantly modulated by URE3-BP 23 27 50 54 p,0.0001
All E. histolytica promoters 6527 1985 8522 23
Promoters with multiple URE3
Promoters which did not
contain at least 2 URE3
matrices
Transcripts significantly modulated by URE3-BP 40 10 50 20 p=0.0031
All E. histolytica promoters 7862 660 8522 8
Motif Frequency in Promoters
Nonamers not in motif URE3 motifs potential motifs
(sequence divided by
motif length 9 bp)
Transcripts significantly modulated by URE3-BP 1905 39 1944.4 2 p=0.0025
All E. histolytica promoters 327360 4051 331411 1.2
A contingency table x
2 test was used to compare the occurrence of the URE3 motif in transcripts significantly modulated by URE3 (the numbers were to large for the
Fishers exact test). The motif background in all E. histolytica promoters was determined using a custom motif search script. To clearly illustrate the data we show the
analysis on a promoter basis, and motif frequency per sequence nonamer.
doi:10.1371/journal.pntd.0000282.t001
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www.plosntds.org 3 August 2008 | Volume 2 | Issue 8 | e282Figure 1. URE3 Matrix Discovery. (A) Representative electrophoretic mobility shift assay (EMSA) performed with radioactively labeled hgl5-URE3
double-stranded DNA. The lanes with probe alone are indicated; all other reactions included 2 mgo fE. histolytica nuclear extract. EMSA’s were
performed with a Klenow-radiolabeled double stranded DNA oligonucleotide that spanned the URE3 motif within the hgl5 promoter
TGTTCCAAAAAGATATATTCTATTGAAAATAAAAGAAG (hgl5-URE3). A ten fold excess of either cold hgl5-URE3 (wt), or an oligonucleotide with a
base pair substitution within the URE3 motif, was used as a competition to the wild type oligonucleotide. These are indicated by position and base
substitution (i.e. T4C indicates that the T at position 4 in the URE3 motif [TATT4CTATT] was changed to a C). The image was generated with a
PhosphorImager (Molecular Dynamics model 425) in conjunction with the Adobe PhotoShop software program. (B) DNA-binding profile of URE3-BP
derived from the EMSA results. The intensity of an irrelevant control was set as 100% and competition of the wild type oligonucleotide set as 0% (y
axis). The position and base changes in the competing oligonucleotides T1A2T3T4C5T6A7T8T9 are shown on the x axis. The results of three
independent replicates were averaged and are shown as a mean with standard error. (C) Graphical representation of the URE3 consensus sequence.
The percent contribution of each base to the total competition occurring at each position (from each of the four bases) was calculated and shown
graphically using the sequence logo program of Crooks et al.
doi:10.1371/journal.pntd.0000282.g001
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Microarray data analysis was performed using the Array Data
Analysis and Management System (VBI) (http://pathport.vbi.vt.
edu/main/microarray-tool.php). The system uses publicly available
tools such as Bioconductor [31] for analysis of the data. Briefly,
statistical significance was determined for the microarray data using
the Linear Models for Microarray Data (LIMMA) program as
described in the results section [32,33]. The statistical significance p
values were corrected using the Benjamini and Hochberg false-
discovery-rate test (FDR#0.05) [34]. Our comparisons were both
between the two strains, and between different time points giving us
potentially three control conditions. The most comprehensive
comparison was between the test and control strains at 9 h post-
induction. Statistical significance was determined for the qRT-PCR
results using the students T test and the non-parametric Kruskal-
Wallis Test was used to determine significance in the reporter gene
assays. URE3 associated promoters were compared to the frequency
of motif appearance in all E. histolytica promoters using the chi-
squared test (InStat 2.03 program (GraphPad Software)).
Transwell migration assays
Transwell migration assays were performed using 5 mm
transwell inserts (8 mm pore size Costar) suspended by the outer
rim within individual wells of 24-well plates. Briefly, ameba
trophozoites were incubated in serum free growth media
containing 2 mg/ml CellTracker Green CMFDA (Molecular
Probes) for 1h [35]. Trophozoites were then washed and
suspended at a concentration of 2610
5/ml in serum free media
and 500 ml loaded into the upper chamber. The plates were then
placed in anaerobic bags (GasPak 100 Anerobic system; BD
Biosciences) and incubated at 37uC for 3 h. Inserts and media
were removed and fluorescence measured using a SpectraMax M2
fluorescent plate reader. Fluorescence versus concentration for
each sample was determined by using a standard curve. Ameba
numbers confirmed in selected experiments by microscopic
counting and by use of the Techlab E. histolytica II antigen test
used according to the manufacturer’s directions.
Results
URE3 Matrix
Electrophoretic mobility shift analysis (EMSA) was used with base
substituted oligonucleotides to define the consensus URE3 motif.
The impact of adding an excess of a non-radioactive oligonucleotide
with a base pair alteration within the URE3 motif T1A2T3T4C5-
T6A7T8T9. was measured. A representativegel showing competition
with the motif modified at positions 1 (AATTCTATT, GATTC-
TATT, CATTCTATT) or 4 (TATACTATT, TATGCTATT,
TATCCTATT) is shown in Figure 1A. The efficacy of a substituted
base in competition assays was compared to the wild type motif
(100%) and an irrelevant control (0%), as shown in Figure 1B. The
percent contribution of each base to the total competition occurring
ateachposition (from eachofthe fourbases) wasthencalculated and
is shown graphically in Figure 1C. The consensus URE3 motif
incorporated base substitutions that maintained at least 15%
competition of the gel shifts. The prototypic URE3 motif
T1A2T3T4C5T6A7T8T9 as a result was modified to a consensus
motif of T1[atg]2T3[tc]4[cg]5T6[at] 7[tgc]8[tg]9.
Verification of the matrix by reporter gene assays
We tested whether URE3 mutations that prevented competition
in EMSAs (Figure 1), also blocked URE3 function in a transfected
promoter. Key bases within the hgl5 promoter URE3 motif were
mutated: T4A, T4CT 4G and C5A. These mutant promoter
sequences were placed upstream of the luciferase reporter gene.
Luciferase values from at least three independent experiments with
two different DNA preparations were performed (Figure 2). De-
repression of the promoter in all base changes assayed indicated
that these bases were critical for the binding of URE3-BP (which
acts as a repressor in the hgl5 promoter context). This included the
promoter with the mutation T4C. In the EMSA assay the T4C
oligonucleotide affinity for URE3-BP was approximately 50% of
the wild type oligonucleotide. We interpreted this as a conse-
quence of the lower sensitivity of the episomal reporter assays,
likely due to over-expression of episomal constructs.
Microarray analysis
To further evaluate the physiological relevance of the URE3
matrix, a calcium-insensitive mutant of URE3-BP (EF(2)mu-
tURE3-BP) (Figure 3A), and therefore constitutively active, was
inducibly expressed and the changes in gene expression measured
by use of an Affymetrix custom array (E_his-1a520285).
The array included probes to 6,385 E. histolytica ORFs. Total
RNA (12 mg) was isolated before induction (–Tet) and after 9 h of
induction (+Tet) from cells carrying the myc-tagged recombinant
URE3-BP mutant or the control construct (containing a stop codon
immediately after the N terminal myc tag). The expression of the
mRNA encoding the recombinant calcium-insensitive dominant
positivemutantURE3-BPwasinduced10–15foldatninehourspost
induction as indicated by myc specific qRT-PCR (Figure 3B). A
western blot of E. histolytica nuclear and cytoplasmic proteins, probed
with a myc-specific antibody, confirmed the cytosolic and nuclear
distribution of both wild type and recombinant protein (Figure 3C).
Ac a l c i u mi n s e n s i t i v eE M S Aw i t hhgl5-URE3 occurred only in
nuclear extracts prepared from EF(2)mutURE3-BP transformed
trophozoites(Figure3D).InlowcalciumconditionsEF(2)mutURE3-
BP and STOP-EF(2)mutURE3-BP had equivalent URE3 binding
capacity (data not shown).
Figure 2. Transcriptional Activity of the URE3 Motif as
Assessed by URE3-driven Repression of a Reporter Gene. The
hgl5 promoter (wild type and containing the T4A, T4C, T4G and C5A
mutations) was placed upstream of the luciferase reporter gene. These
constructs were transfected into cultured E. histolytica trophozoites.
Mutations (T4A and C5A) identical to those within the competing
oligonucleotides were made within the hgl5 promoter URE3 motif.
Luciferase values from at least three independent experiments with two
different DNA preparations were performed. Luciferase values stan-
dardized to wt (100%) are shown as means with standard error.
Promoter activity as a % of wild type is shown on the y axis and position
and base mutated in the promoter on the x axis. All mutants were
statistically different from the wild type promoter (p,0.0001 using the
non-parametric Kruskal-Wallis Test).
doi:10.1371/journal.pntd.0000282.g002
Targets of the Transcription Factor URE3-BP
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The complete microarray data (deposited in NCBI’s Gene
Expression Omnibus [36] and accessible through GEO Series
accession number GSE12188 (http://www.ncbi.nlm.nih.gov/geo/
query/acc.cgi?acc=GSE12188) was normalized using gcRMA and
statistical significance determined by LIMMA statistical analysis
(Table S2). A total of fifty mRNAs were increased or decreased $2-
fold at 9h post-induction compared to the induced control strain in
which an N-terminal stop codon was present in the EF(2)URE3-BP
sequence (Figure 4). The filtered transcripts had a normalized signal
intensity of .50 in at least one microarray experiment, a change of
greater than 2 fold, and were statistically significant by LIMMA.
Analysis of modulated transcripts
A total of fifty mRNAs were increased (8) or decreased (42) $2-
fold at 9h post-induction compared to the induced ‘‘control stop’’
strain, which had a stop codon inserted after the sequence encoding
the myc tag. To identify the novel URE3-BP regulated genes, the
promoters of transcripts significantly modulated by two-fold or
greater were scored for the presence orabsence of the URE3 matrix.
The DNA Pattern Find program (http://bioinformatics.org/sms/)
was used to locate the URE3matrixinputativepromotersof URE3-
BPresponsive genes(Figure4 and Table2).Incaseswhere theprobe
set represented a ‘family’ of highly similar transcripts the probe set
was scored positive if any of the promoters contained a URE3 motif.
The three family probe sets are indicated in Table 2.
The URE3 matrix was found in 23% of all predicted promoter
regions, however the matrix appeared at a statistically greater
frequency (54%) in the URE3-BP modulated transcripts predicted
by LIMMA (chi-square test p.0.0001). Alternative analysis using
the motif frequency or requiring the presence of two or more
motifs for the positive designation also confirmed the correlation
between the URE3 motif and transcript modulation (Table 1).
The presence of the URE3 motif in the 39 UTR regions was not
above background values. The breakdown of the motifs found in
the promoters of putative URE3-BP targets is shown in Table 2
and a graphical representation of the observed URE3 motifs is
shown in Figure 4C. The sequence consensus of the URE3 motifs
found 59 of the modulated transcripts displayed only A or T
residues at motif positions 2 and 7. While positions 2 and 7 were
found to be the least conserved positions in the URE matrix
consensus the predominant substitution of A/T may be a
reflection of the AT bias of the Entamoeba genome. The other
predominant change was a G substitution at position five which
was half as effective as the wild type motif in EMSA assays (C5G).
InterPro was used to scan the open reading frames of the
significantly modulated genes to obtain additional information on
protein function, TMpred to predict transmembrane regions, big-
PI Predictor to identify Glycosylphosphatidylinisotol (GPI) an-
chored proteins (GPI-anchor) and SignalP to identify signal
peptides [37,38,39]. Sequences 150 bp 59 and 39 of the annotated
ATG start codons were also checked and any additional in-frame
peptides also examined for the presence of a signal peptide. On the
basis of this information, the majority of the transcripts (47 of 50)
could be subdivided into four categories: membrane proteins,
Figure 3. Inducible Overexpression of a Calcium-Insensitive
Mutant of URE3-BP (EF(2)mutURE3-BP) in E. histolytica. A
recombinant version of URE3-BP was generated by mutating one of the
two EF-hand motifs of URE3-BP (associated with the ability to bind
calcium,EF(2)mutURE3-BP[10])andbyintroducinganNterminalmyctag.
As calcium inhibited DNA binding by URE3-BP, this generated a dominant
positive mutant [10]. The recombinant protein was placed under the
control of a tetracycline-inducible gene expression system of E. histolytica
(previously described by Ramakrishnan et al. [27]). As a control, in a
second construct the initial N terminal sequence of URE3-BP was replaced
by the sequence CTTGTATTTAACAATAGCTAACATC, mutated bases
underlined, which introduced stop codons into the two open reading
frames at the N terminus. (A) Cartoon showing the salient features of the
constructs. (B) qRT-PCR of un-induced and induced ameba transfected
with the pEF((2))mutURE3-BP. Results are normalized to the levels of lgl1
and shown as a percentage of values of ameba induced for 9 h (y axis).
Time after induction is shown on the X axis. (C) Western blot of nuclear
and cytoplasmic extracts from tetracycline-induced and un-induced
amebae probed with an antibody specific for the myc tag and therefore
the recombinant protein (9E10), as well as with a monoclonal antibody to
URE3-BP (4D6). (D) Calcium insensitive binding to URE3 DNA in extract
prepared from EF(2)mutURE3-BP transformed trophozoites. EMSA per-
formed with added calcium and radioactively labeled hgl5-URE3 double-
stranded DNA. Other than the lane with probe alone, reactions included 2
mgo fE. histolytica nuclear extract prepared from either induced
trophozoites carrying EF(2)mutURE3-BP or as a control STOP- EF(2)mu-
tURE3-BP. A six fold excess of either cold hgl5-URE3 (wt), or an
oligonucleotide with a base pair change which substituted a G for a T
at the first position and had no impact on URE3-BP specific band
formation (T1G mut) were added as shown.
doi:10.1371/journal.pntd.0000282.g003
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URE3 associated transcripts are shown in Table 2.
A gene was assigned to the membrane encoding group on the
basis of the annotated GO term, the presence of a signal peptide, a
GPI-anchor signal, or transmembrane domain. The majority of
the membrane gene promoters contained a URE3 matrix (73%
p,0.0001).
The encoded membrane proteins were quite distinct at the
protein level. However, a subgroup of these proteins had highly
similar promoter, and amino- and carboxyl-terminal sequences
(sites of signal peptide and transmembrane domains) (Figure 5).
With one exception (EHI_163360), the predicted sizes, pI, and
length of the proteins were also quite similar (molecular mass
between 29 to 47 kDa, and pI 4.3 to 5.5). In addition, all these
Figure 4. Comparison of E. histolytica Gene Expression upon Inducible Expression of EF(2)mutURE3-BP and STOP- EF(2)mutURE3-
BP. (A) Heat map generated from microarray data reflecting gene expression values. Each column represents a microarray. Each row represents the
expression pattern of one probe set across microarrays. The source of the RNA hybridized to each chip is indicated at the top of the columns. The
ratios of transcript levels between experiments are color-coded in red and green. Red represents an increase of the transcript level of a gene in the
transcript signal in this array compared to the expression of the transcript in induced STOP- EF(2)mutURE3-BP and green represents a decrease as
indicated by the figure color bar. The genes modulated on induction of EF(2)mutURE3-BP, as compared to STOP- EF(2)mutURE3-BP are organized by
functional category as shown in Table 2. Transcripts that had a potential URE3 matrix in the sequences 2375-25bp 59 of the start ATG codon, are
indicated and detailed in Table 2 changes in transcript levels verified by qRT-PCR are marked by an asterisk (*). (B) Color bar scale of log2 transformed
intensities. (C) Graphical representation of the observed URE3 sequences. The percent representation of the nucleotide occurring at each position
(from each of the four bases) shown graphically using the sequence logo program of Crooks et al [53].
doi:10.1371/journal.pntd.0000282.g004
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Pathema Loci ID Annotation Fold Change
Position of URE3
59 of ATG
Location of Other
URE3 motifs Motif Orientation
1
Proteins With Signal Peptides
EHI_062960 membrane protein, receptor-mediated
transport
2,3
4.19 133 124 TATTCTtTT 2
EHI_010850 EhCP-A2 &7 2.38 275 TATTCTATT +
EHI_046650 membrane protein, similar to Gal/GalNAc
lectin heavy subunit
4
22.01 134 113 Tt/gTTCTATT 2
139
EHI_166370 membrane protein 22.07 182 35 TATTCTATT/g 2
EHI_183210 membrane protein
4,5 22.07 209 TtTTCTATT 2
EHI_067910 Competence protein ComEC
4 22.16 113 TATTCTtTT +
EHI_084730 multidrug resistance-associated protein
2 22.28 147 TATTCTtTT +
EHI_120930 transmembrane protein kinase
4 22.28 125 140 TATTC/gTATT +
EHI_057430 membrane protein, surface antigen ariel1
family
6
22.47 46 TgTTCTATT 2
EHI_145850 membrane protein 22.61 125 TATTGTATT 2
EHI_103900 membrane protein, nucleosome-binding
protein 1
23.3 46 127 TA/tTTGTATT 2
EHI_132250 membrane protein 23.53 118 TATTGTATT 2
EHI_114000 membrane protein 25.26 46 127 TA/tTTGTATT 2
EHI_109010 membrane protein
6 25.67 46 TtTTCTATT 2
EHI_146100 membrane protein 26.11 46 TtTTCTATT 2
EHI_163360 membrane protein
6 26.56 46 TATTGTATT 2
Cytoskeletal associated proteins
EHI_154330 Calponin homology domain
2 23.38 261 343 TATTCTtTT 2
Metabolic enzymes
EHI_065250 membrane protein, Lecithin:cholesterol
acyltransferase
5.25 106 TATTCTtTT 2
EHI_079300 acyl-CoA synthetase 2.98 362 TATTCTATT +
EHI_092490 Protein with a weak similarity to
sulfotransferases
2,7
2.58 78 217 TATTC/gTT/tTT +
EHI_090430 Protein with a weak similarity to
sulfotransferase
7,8
2.52 223 TtTTCTATT 2
EHI_005060 Fe-hydrogenase
9 2.35 140 TtTTCTATT 2
EHI_185240 long-chain-fatty-acid--CoA ligase 22.43 157 193 TtTTCTATT 2
DNA transcription/translation
EHI_004480 basic leucine zipper protein
3 2.36 80 89 TA/tTTCTATT 2
EHI_059690 chromosome segregation COG 1196 22.33 51 TATTCTtTT 2
EHI_158020 transcription initiation factor IIIB chain BRF 22.57 35 TATTCTtTT 2
EHI_000780 chromodomain-helicase-DNA-binding
protein
4
22.94 128 TATTCTtTT 2
Identity (Pathema Locus number) and gene annotation of significantly modulated genes are shown in conjunction with the observed change between induced
EF(2)mutURE3-BP and STOP- EF(2)mutURE3-BP strains. The distance between the URE3 motif and the presumed initiating ATG codon is shown as is the position of other
potential URE3 motifs, the promoter consensus URE3 motif, and orientation.
1If the motif is present in the promoter in a 59 to 39 direction this is indicated by (+) and on the reverse strand by (2).
2These transcripts were decreased in recent clinical isolates [4]
3Was modestly induced by tetracyclin at below threshold values
4These transcripts were increased in recent clinical isolates [4]
5This probe set recognizes a gene shown to be up regulated in HM-1:IMSS compared to a Rahman strain [3]
6A signal peptide was found in either the 59 extended open reading frame or 39 of initiating ATG, the position of URE3 motif is shown from the newly designated
initiating ATG
7Annotation on the basis of homology to known sulfotransferases
8This transcript was also significantly increased in the EF(2)mutURE3-BPuninduced ameba compared to the uninduced control.
9This gene was described by Nixon et al and has been shown to be up regulated in HM-1:IMSS compared to a Rahman strain [3,45]
doi:10.1371/journal.pntd.0000282.t002
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terminus, and an anterior potential GPI anchor cleavage/addition
site [40].
Most of the promoters of the small group of genes encoding
metabolic enzymes also contained a URE3 matrix (86%
p,0.0001). The enzymes encoded by these genes were linked to
phospholipid metabolism. The opposing regulation of two
enzymes that catalyze the addition of Coenzyme A to fatty acids
(EHI_079300 and EHI_185240) might reflect different substrate
specificities of these enzymes [41]. Both could potentially use the
fatty acids, which are produced as a consequence of the
breakdown of phospholipids by phospholipid:diacylglycerol acyl-
transferase (PDAT) (Figure 6) [42]. No URE3 matrix was found
upstream of the fourth transcript, fatty acid elongase
(EHI_092190), which could also be potentially involved in this
potential scavenger cell pathway.
EF(2)mutURE3-BP expression induced migration of
amebic trophozoites
To determine whether URE3-BP regulated the promigratory
effects of trophozoites, transwell migration assays were performed
as described in materials and methods. A two fold increase in
migrating trophozoites was observed when comparing ameba
induced to express EF(2)mutURE3-BP to uninduced controls
(p=0.04) or to the induced control stop strain transfected with the
construct STOP- EF(2)mutURE3-BP (p=0.02) (Figure 7). No
difference was observed in migration when uninduced or induced
STOP- EF(2)mutURE3-BP were compared (data not shown).
Discussion
In this work the DNA consensus motif recognized by the
URE3-BP transcription factor was experimentally defined, and
Figure 5. Modulated Transcripts Encoding Potential Membrane Proteins. Sequences were clustered using the ClustalW program. A)
Promoter sequences B) Protein sequence at the amino terminal C) Protein sequence at the carboxyl terminal. Numbering is from initial methionine
codon or amino acid. * open reading frames where an alternative from the database initiating methionine was used. Potential URE3-BP binding sites
are underlined.
doi:10.1371/journal.pntd.0000282.g005
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by inducible expression of URE3-BP. URE3-BP had previously
been shown to regulate the expression of two virulence factors in
the parasite. The current studies provide a more global picture of
its role in control of gene expression. The key experimental
approach was the inducible expression of a dominant positive
URE3-BP mutant and the subsequent identification of uniquely
altered transcripts. The majority (42/50) of transcripts were
repressed. Over half (54%) of the modulated genes had a URE3
matrix in the promoter region while the other half was comprised
of genes presumably downstream of control by URE3.
The URE3 matrix was present in the 59 sequences of URE3-BP
modulated genes involved in fatty acid metabolism and in
potential membrane or secreted proteins. The latter suggests that
phenotypic changes due to the expression of the dominant positive
URE3-BP mRNA could occur most noticeably at the cell surface
of E. histolytica trophozoites.
URE3-BP regulated genes, which encoded proteins with an N
terminal signal peptide, included the potential virulence factor
EhCP-A7, a cysteine protease, an asparagine-rich antigenic
surface protein ariel [43,44], a novel lectin-like protein, and a
subgroup of genes encoding potential surface proteins which
appear to have highly conserved promoters and signal peptides.
Most unusually the conservation in this group of potential surface
proteins was greater at the DNA rather than the protein level. This
may represent a gene duplication followed by functional
divergence, or possibly a gene recombination event.
A technical limitation of the gene expression analysis was the
inability to measure transcript levels of the hgl5 and fdx1 genes that
contain URE3 in their promoters, which cannot be distinguished
from highly related gene family members that lack URE3-
containing promoters. The hgl5 gene belongs to a family of five
highly similar genes (up to 99%), and ferredoxin is encoded by two
identical ORFs, fdx1, and fdx2 (confirmed by Gilchrist et al
unpublished data). The presence of the URE3 matrix was not
much higher than background in the promoters encoding genes
involved in either transcription/translation (25% p=0.035) or
cytoskeletal function (25% p=0.73).
However while we could not demonstrate changes in the level of
the ferredoxin transcript, a URE3 associated Fe-hydrogenase
EHI_005060 (EC 1.12.7.2) [45], which may be expected to reduce
ferredoxin was statistically significantly up-regulated (over two-fold).
Four of the other six metabolic enzymes identified by inducible
expression of URE3-BP could be linked in a phospholipid
degradation/ fatty acid assimilation pathway (Figure 6). A
potentially rate limiting step in a fatty acid biosynthesis pathway
appeared to be closely modulated by opposing regulated acyl-
Coenzyme A synthetases (acyl-CoA synthetases). The modulated
pathway may be involved in the hydrolysis of phospholipids to
form fatty acids and important in modification of the cell
membrane lipid content [46]. The inclusion of short chain fatty
acids in the E. histolytica growth media has no impact on either the
URE3-BP transcript or on the genes involved in this pathway,
suggesting the lack of feedback inhibition of URE3-BP from the
products of this pathway [17].
A limitation of this study was that the microarray analysis
measured the steady state mRNA levels and we therefore may
have missed changes in newly transcribed RNA, especially for
abundant transcripts. Changes occurring in mRNA stability and/
or transcript processing may obscure changes occurring at the
level of transcription [47,48]. A second limitation is that the high
‘background’ incidence of the URE3 motif (23%) in the promoters
of all E. histolytica may indicate that there are other factors not yet
identified involved in promoter specific recognition by URE3-BP.
Because appreciable levels of wild type URE3-BP were still
present, this might have contributed to the failure to observe
changes in the roughly 2000 genes with putative URE3-BP
binding sites for which no change was seen following induction of
EF(2)mutURE3-BP. Because of these issues it is a reasonable
conclusion that the 50 changed transcripts are an underestimate of
the genes regulated by URE3-BP.
The URE3 matrix was absent in 23 of the regulated promoters.
Amebae were harvested at nine hours after the addition of
Figure 6. Modulation of Transcripts Encoding Enzymes In-
volved in Phospholipid Degradation and Fatty Acid Biosyn-
thesis. Transcripts significantly modulated by (EF2)mutURE3-BP are
shown in shaded boxes, green indicates a down-regulated transcript
and red an up-regulated transcript. As lecithin:cholesterol acyltransfer-
ase has homology with phospholipid:diacylglycerol acyltransferase the
simpler pathway of triacylglycerol biosynthesis is shown although
alternative pathways exist [42,54]. The locus number and the URE3
motif present within the promoter sequences follow the gene name.
doi:10.1371/journal.pntd.0000282.g006
Figure 7. EF(2)mutURE3-BP expression induced migration of
amebic trophozoites. Expression of the EF(2)mutURE3-BP and STOP-
EF(2)mutURE3-BP transcripts was induced by the addition of tetracy-
cline. Analysis of trophozoite migration was then done by a transwell
assay. Data shown are representative of assays using two independ-
ently transfected trophozoite lines with the relevant expression vectors
in 4 separate experiments. The data are shown as mean 6 SEM of the
number of cells migrated measured using CellTracker
TM Green CMFDA
as described in Materials and Methods.
doi:10.1371/journal.pntd.0000282.g007
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nant URE3-BP protein (Figure 3B). Therefore it is possible that at
this time point URE3-BP regulated transcripts may have in turn
induced the expression of a set of secondary-response genes [49].
The URE3 associated EHI_004480 ORF encoding a protein with
a basic leucine zipper domain, and the EHI_000780 transcript
that encodes a potential chromodomain protein, could act as
regulators of a secondary response. Among the modulated non-
URE3 associated transcripts are members of the virulence
associated EhSTIRP family [3,50] and cytoskeletal genes suggest-
ing a potential involvement in attachment or motility [19]. The
promigratory impact of URE3-BP overexpression shown in
Figure 7 supported this correlation however identifying truly co-
regulated genes is very difficult with this limited data set [51,52].
In conclusion, we have identified a group of genes, which
appear to be regulated by URE3-BP. These genes and their
products may represent a network of interconnected responses to
environmental signals. The biological consequences of these
changes may impact the ability of the organism to colonize the
host, and/or control its invasive behavior.
Supporting Information
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Found at: doi:10.1371/journal.pntd.0000282.s001 (0.04 MB
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